Collectively, the enhanced antitumor efficacy of imNAαPD1 & αPDL1 in multiple tumor models indicated that imNA could extend the therapeutic potential of PD1/PDL1 blockade to a broader range of tumor types. The gene discussed is CD274; the disease is neoplasm.